Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2746–2760 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3485
WT1 Gene (Wilms Tumor Type 1, Familial) Genetic Test

This test evaluates the WT1 gene for pathogenic variants associated with an increased risk of developing Wilms tumor type 1.

Whole blood, FTA card, or extracted DNA 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WT1 gene coding regions", "WT1 gene splice-site junctions"]
Parameters
[]
Preparation
[]
Indications
["Family history of Wilms tumor", "Early-onset kidney cancer in family", "Bilateral or multifocal Wilms tumor", "Known WT1 pathogenic variant in a first-degree relative"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93716-8 ICD-10: Z15.09
Clinical summary
This test evaluates the WT1 gene for pathogenic variants associated with an increased risk of developing Wilms tumor type 1.
TEST-4315
WWOX Gene NGS Test for Early Infantile Epileptic Encephalopathy Type 28 (EIEE28)

This test identifies pathogenic variants in the WWOX gene associated with early infantile epileptic encephalopathy type 28 (EIEE28). It provides a definitive molecular diagnosis fo...

Peripheral whole blood (EDTA) or dried blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WWOX gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Confirmation of suspected EIEE28", "Genetic diagnosis in infants with specific neurological symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81329-4 ICD-10: G40.4
Clinical summary
This test identifies pathogenic variants in the WWOX gene associated with early infantile epileptic encephalopathy type 28 (EIEE28). It provides a definitive molecular diagnosis for this severe neurogenetic disorder.
TEST-5750
WWOX Gene Spinocerebellar Ataxia Type 12, Autosomal Recessive Next‑Generation Sequencing (NGS) Genetic Test

This genetic test analyzes the WWOX gene to detect pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 12 (SCAR12).

Peripheral Whole Blood, Serum, or Plasma 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WWOX gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Suspected diagnosis of Spinocerebellar Ataxia Type 12 (SCAR12)", "Family history of SCAR12", "Progressive neurological symptoms consistent with SCAR12"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81658-3 ICD-10: G11.8, Z15.09, Z13.71
Clinical summary
This genetic test analyzes the WWOX gene to detect pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 12 (SCAR12).
TEST-4755
XBP1 Gene Genetic Testing for Major Affective Disorders Test

This test identifies genetic variants in the XBP1 gene associated with an increased risk of developing major affective disorders.

Peripheral Whole Blood (3–5 mL EDTA tube) or DNA FTA Card 21–28 Days (3 to 4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["XBP1 gene variants", "Pathogenic variants in coding exons and flanking intronic regions"]
Parameters
[]
Preparation
["Pre-test genetic counseling session required", "Provide list of current psychiatric medications"]
Indications
["Suspected genetic predisposition to major affective disorders", "Risk stratification for bipolar disorder", "Risk stratification for recurrent major depressive disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98538-4 ICD-10: F30–F39
Clinical summary
This test identifies genetic variants in the XBP1 gene associated with an increased risk of developing major affective disorders.
TEST-5810
XDH Gene Xanthinuria Type 1 Genetic Test

This test evaluates the XDH gene for pathogenic variants associated with hereditary xanthinuria type I.

Peripheral blood (whole blood) or FTA card specimen 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XDH gene", "Genetic cause of xanthinuria type I"]
Parameters
[]
Preparation
["No fasting or dietary changes required", "Genetic counselling session required before testing"]
Indications
["Diagnosis of hereditary xanthinuria type I", "Evaluation of recurrent kidney stones with low uric acid"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21629-3 ICD-10: E79.8
Clinical summary
This test evaluates the XDH gene for pathogenic variants associated with hereditary xanthinuria type I.
TEST-3212
XIAP Gene Lymphoproliferative Syndrome, X-Linked Type 2, Genetic Test

This genetic test identifies pathogenic mutations in the XIAP gene, confirming a diagnosis of X-linked lymphoproliferative syndrome type 2 (XLP-2).

Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card) 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["XIAP gene sequence", "Pathogenic variants in XIAP"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustment needed"]
Indications
["Males presenting with recurrent or familial HLH", "Hypogammaglobulinemia", "Splenomegaly", "Maternal family history suggestive of XLP"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101373-6 ICD-10: D82.3
Clinical summary
This genetic test identifies pathogenic mutations in the XIAP gene, confirming a diagnosis of X-linked lymphoproliferative syndrome type 2 (XLP-2).
TEST-4859
XK Gene (McLeod Syndrome with or without Chronic Granulomatous Disease) Genetic Test

This test evaluates the entire XK gene for pathogenic variants associated with McLeod syndrome and potentially Chronic Granulomatous Disease (CGD). It utilizes Next-Generation Sequ...

Peripheral Whole Blood (EDTA), 3–5 mL 3–4 Weeks (Expedited available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XK gene", "Deletion/duplication analysis of the XK gene"]
Parameters
[]
Preparation
["No fasting or special preparation is needed."]
Indications
["Suspected McLeod syndrome", "Suspected Chronic Granulomatous Disease (CGD)", "Unexplained neurological symptoms consistent with neuroacanthocytosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21649-0 ICD-10: G24.8, E75.6
Clinical summary
This test evaluates the entire XK gene for pathogenic variants associated with McLeod syndrome and potentially Chronic Granulomatous Disease (CGD). It utilizes Next-Generation Sequencing (NGS) with deletion/duplication analysis.
TEST-2610
XK Gene Genetic Test for McLeod Syndrome & CGD

This test evaluates the XK gene for pathogenic variants associated with McLeod syndrome and assesses for contiguous deletions involving the CYBB gene linked to X-linked CGD.

Whole Blood (EDTA tube), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XK gene", "Contiguous deletions involving XK and CYBB genes"]
Parameters
[]
Preparation
["Clinical history must be provided", "Mandatory genetic counseling session required", "No fasting required"]
Indications
["Suspected McLeod syndrome", "Suspected X-linked Chronic Granulomatous Disease (CGD)", "Family history of McLeod syndrome or CGD", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 74500-4 ICD-10: G23.0, D70.4
Clinical summary
This test evaluates the XK gene for pathogenic variants associated with McLeod syndrome and assesses for contiguous deletions involving the CYBB gene linked to X-linked CGD.
TEST-3599
XPNPEP3 Gene Nephronophthisis-Like Nephropathy Type 1 Genetic Test

This test evaluates the XPNPEP3 gene for pathogenic variants associated with nephronophthisis-like nephropathy type 1 (NPHPL1).

Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XPNPEP3 gene", "Copy number variations (CNV) in the XPNPEP3 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid sample contamination"]
Indications
["Suspected diagnosis of nephronophthisis-like nephropathy type 1", "Family history of NPHPL1", "Autosomal recessive inheritance pattern suspected"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79241-2 ICD-10: Q61.5
Clinical summary
This test evaluates the XPNPEP3 gene for pathogenic variants associated with nephronophthisis-like nephropathy type 1 (NPHPL1).
TEST-3041
XPR1 Gene Sequencing Test

This diagnostic test evaluates the XPR1 gene for variants associated with idiopathic basal ganglia calcification type 6.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic and likely pathogenic variants in the XPR1 gene", "Single Nucleotide Variants (SNVs)", "Insertions and Deletions (indels)"]
Parameters
[]
Preparation
["Fasting is not required", "Continue all prescribed medications unless advised otherwise by your physician"]
Indications
["Diagnosis of idiopathic basal ganglia calcification type 6", "Familial cascade screening for XPR1-related disorders", "Clinical management guidance for neurologists and geneticists"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: G23.8, Z13.79, Z14.8
Clinical summary
This diagnostic test evaluates the XPR1 gene for variants associated with idiopathic basal ganglia calcification type 6.
TEST-6291
XRCC2 Gene Fanconi Anemia (XRCC2-Related) Genetic Test

This genetic test identifies pathogenic variants in the XRCC2 gene associated with Fanconi anemia.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XRCC2 gene"]
Parameters
[]
Preparation
["Provide detailed personal and family clinical history", "Attend a genetic counseling session"]
Indications
["Diagnosis confirmation of Fanconi anemia", "Assessment of cancer predisposition", "Family risk assessment", "Evaluation of unexplained cytopenias"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101348-0 ICD-10: D61.09
Clinical summary
This genetic test identifies pathogenic variants in the XRCC2 gene associated with Fanconi anemia.
TEST-2117
XRCC3 Gene (Breast Cancer Susceptibility) Genetic Test

This test evaluates the XRCC3 gene for pathogenic variants associated with an increased risk of hereditary breast cancer.

Whole blood EDTA 3 to 4 weeks from specimen receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["XRCC3 gene sequence", "Copy Number Variations (CNVs) in XRCC3"]
Parameters
[]
Preparation
["Stay well hydrated", "Bring valid UAE national ID or Emirates ID", "Bring prior genetic test reports (if available)", "Bring detailed family history of cancer (if available)", "No fasting required"]
Indications
["Family history of breast or ovarian cancer", "Personal history suggestive of hereditary cancer syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: Z15.01
Clinical summary
This test evaluates the XRCC3 gene for pathogenic variants associated with an increased risk of hereditary breast cancer.
TEST-2881
XYLT1 Gene Desbuquois Dysplasia Type 2 Genetic Test

This test identifies genetic variants in the XYLT1 gene associated with Desbuquois dysplasia type 2.

Peripheral whole blood, FTA card dried blood spot, or previously extracted genomic DNA 21–28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["XYLT1 gene sequence", "Pathogenic variants in XYLT1"]
Parameters
[]
Preparation
[]
Indications
["Clinical and radiographic suspicion of Desbuquois dysplasia type 2", "At-risk family members", "Reproductive risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81260-5 ICD-10: Q77.8
Clinical summary
This test identifies genetic variants in the XYLT1 gene associated with Desbuquois dysplasia type 2.
TEST-4164
YARS1 Gene DI‑CMTC Genetic Test

This test evaluates the entire coding sequence of the YARS1 gene for pathogenic variants associated with DI‑CMTC.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the YARS1 gene", "Single-nucleotide variants", "Insertions", "Deletions"]
Parameters
[]
Preparation
["A documented clinical history must be completed before sample collection", "A formal genetic counselling session must be completed before sample collection", "Pedigree chart construction must be completed before sample collection"]
Indications
["Suspected diagnosis of distal hereditary motor neuropathy with cataracts and mild intellectual disability (DI‑CMTC)", "Genetic aetiology suspected"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51966-5 ICD-10: G60.0
Clinical summary
This test evaluates the entire coding sequence of the YARS1 gene for pathogenic variants associated with DI‑CMTC.
TEST-5259
YARS2 Gene Myopathy, Lactic Acidosis, and Sideroblastic Anemia Type 2 Genetic Test

This genetic test analyzes the YARS2 gene to identify mutations causing Myopathy, Lactic Acidosis, and Sideroblastic Anemia type 2 (MLASA2).

Peripheral Whole Blood (EDTA) or Buccal Swab / FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (Indels)", "Splice-site aberrations", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Inform lab of any medications"]
Indications
["Suspected diagnosis of MLASA2", "Family history of MLASA2", "Evaluation of unexplained myopathy, lactic acidosis, or sideroblastic anemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101645-1 ICD-10: D64.0, G71.3, E87.2
Clinical summary
This genetic test analyzes the YARS2 gene to identify mutations causing Myopathy, Lactic Acidosis, and Sideroblastic Anemia type 2 (MLASA2).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area